FDA label

What is Lyllana used for?

Lyllana contains estradiol. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label for Lyllana lists 2 uses: Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause; Prevention of Postmenopausal Osteoporosis.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Lyllana?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Lyllana, patch, extended release

Indications and Usage, quoted from the label by Amneal Pharmaceuticals LLC (ANDA211396). Cross-references to other label sections are left out.

LYLLANA is indicated for:

Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause

Prevention of Postmenopausal Osteoporosis

Limitation of Use

When prescribing solely for the prevention of postmenopausal osteoporosis, first consider the use of non-estrogen medications. Consider estrogen therapy only for women at significant risk of osteoporosis.

Source: DailyMed label, set id 09c472c6-a38a-4a3d-b048-6fefd52e2ad3, version 15, effective May 15, 2024. NDC 65162-126, one of 5 listings for this product.

Questions

What is Lyllana used for?

The FDA label for Lyllana lists 2 uses: Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause; Prevention of Postmenopausal Osteoporosis.

What drug class is Lyllana?

FDA lists estradiol in the Estrogen established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Lyllana

Try it on your own data today.

Free to start. Most teams are using it the same day.

Get started for freeSee pricing